Search
for
Sort by
Research 61–90 of 1000+
- Comparative Efficacy of Microneedling with and without Topical Vitamin D3 in Localized Alopecia areata
- Role of Pracchanna Karma (bloodletting) followed by Shamana Chikitsa in the Management of Indralupta (Alopecia Areata): A Case Report
- AYURVEDIC MANAGEMENT OF INDRALUPTA(ALOPECIA AREATA): A CASE REPORT
- BH21 Efficacy and safety of oral Janus kinase inhibitors in the treatment of alopecia areata: a systematic review and meta-analysis
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- AYURVEDIC MANAGEMENT OF ALOPECIA AREATA USING VIDDHAKARMA AS A PARA-SURGICAL PROCEDURE: A CASE STUDY
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Effectiveness of Abrocitinib in Adolescent Alopecia Areata: A Prospective Observational Pilot Study
- Trichoscopic Markers and Clinical Response Patterns With Ritlecitinib in Severe Alopecia Areata: 24‐Week Outcomes From a Prospective Real‐World Cohort
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- Long‐Term Real‐World Outcomes of Baricitinib in Severe Alopecia Areata: A 104‐Week Retrospective Analysis From a Single Institute
- Evaluation of the Efficacy of Antihistamines in the combined therapy for Alopecia Areata
- 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
- Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint)
- Efficacité à long terme du baricitinib dans le traitement de la pelade : résultats à la semaine 104 des études BRAVE-AA1 et BRAVE-AA2
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Therapeutic Efficacy of Liquid Nitrogen Cryotherapy for Treatment of Alopecia Areata
- The efficacy and safety of tofacitinib in patients with alopecia totalis
- Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study
- Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double‐blind placebo‐controlled trial
- Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild‐to‐moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator‐blinded trial
- Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata
- Holistic management of Alopecia areata (~Indralupta) using Pracchana karma with derma-roller and Ayurveda intervention: A case report
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Alopesia universalis pada anak yang berespon baik dengan terapi kombinasi: sebuah laporan kasus
- Effectiveness and safety of oral Janus kinase inhibitors in patients aged ≤12 with alopecia areata: a systematic review and meta-analysis